Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
SSE:600613
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
SSE:600613
|
CN |
|
Digital360 SpA
MIL:DIG
|
IT |
|
A
|
Abbott Laboratories
BMV:ABT
|
US |
|
A
|
Argo Blockchain PLC
NASDAQ:ARBK
|
UK |
|
V
|
VCI Global Ltd
NASDAQ:VCIG
|
MY |
|
Avecho Biotechnology Ltd
ASX:AVE
|
AU |
|
Wooboard Technologies Ltd
ASX:WOO
|
AU |
|
Rectron Ltd
TWSE:2302
|
TW |
Intrinsic Value
The
intrinsic value for
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd (600613)
under the Base Case is
hidden
CNY.
Compared with the current market price of 6.36 CNY, the stock appears
hidden
.
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Shanghai Shenqi Pharmaceutical Investment Management Co Ltd usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd.
Fundamental Analysis
Revenue & Expenses Breakdown
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
Earnings Waterfall
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
The
intrinsic value for
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd (600613)
under the Base Case is
hidden
CNY.
Compared with the current market price of 6.36 CNY, the stock appears hidden .
